Nivolumab生物仿制药是一种人单克隆抗体，可阻断PD-1及其配体PD-L1和PD-L2之间的相互作用。纳武利尤单抗是一种IgG 4 κ免疫球蛋白，其计算分子量为146 kDa。在重组中国人卵巢（CHO）细胞系中表达。 Nivolumab生物仿制药-研究级该产品同种型对照：Bulk Human IgG4 Isotype Control (IB4) [ICH2257] 缓冲液：ICH3001-100ml，nICH3002-100ml，nICH3003-100ml， 浓度：1.0 - 5.0 mg/ml 纯度：>95% by SDS-PAGE and HPLC 内毒素：≤ 1.0 EU/mg as determined by the LAL method 制剂：Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.
